OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 03, 2022
For some manufacturers, the goal was to be fully compliant with the DSCSA, including both serialization and aggregation, from day one.
February 01, 2022
Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.
Recipharm will build up its biologics service offering with the acquisition of GenIbet.
Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.
Demand for outsourced services of technical R&D activities is increasing.
Recent news surrounding CDMOs provides insight into ongoing trends in the sector.
A key benefit for companies when outsourcing formulation development is the broad experience they can gain from a dedicated service provider, particularly for niche markets.
Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource.
Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.